Dr. Reddy's Laboratories Limited annual earnings per share (EPS) for fiscal 2026 was ₹51.42, a decrease of 24.1% from ₹67.78 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Diluted EPS | ₹51M | ₹68M | ₹67M | ₹54M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Diluted EPS | ₹5M | ₹3M | ₹15M | — | ₹17M | ₹19M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More DRREDDY metrics: Revenue · Gross Profit · Operating Income · Net Income · Free Cash Flow
All DRREDDY financial statements → Interactive DRREDDY charts →
About TickerBase · Data methodology & sources · Privacy · Terms